NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/12/2024
Voltar para busca
Dado oficial do USPTO
BIONOTE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
10
Data de depósito
04/06/2022
Data de registro
03/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/12/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
10/01/2020
Primeiro uso no comércio
10/01/2020
Código do desenho
4
Tipo de titular
03
Localização do titular
Gyeonggi-do, KR
Examinador
WOLD, BARBARA NIELSEN
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Bionote, Inc.
Representantes
CHANGHOON LEE
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
(Based on Use in Commerce) Medical diagnostic apparatus for testing for viruses; home virus test kits consisting primarily of medical diagnostic test strips for saliva or nasal discharge analysissampling tools being medical swabsbuffers for use in disease testing; medical and veterinary apparatus for analyzing bacteria in biological samples; medical genetic fragment analyzers for use in the veterinary field; medical genetic analyzer for use in the veterinary field; real-time gene amplification equipment for medical use in the veterinary field; immunological analyzers for medical and veterinary use; medical immunoassay apparatus for use in the veterinary field; medical diagnostic testing instruments for use in immunoassay procedure for use in the veterinary field; immunofluorescence analysis apparatus for medical purposes in the veterinary field; immunoassay apparatus for medical diagnosis in the veterinary field; miniaturized sensors for use in gene analysis and diagnosis for medical and veterinary purposes; medical apparatus for use in treating respiratorygastrointestinal diseasetropical diseaseviral hepatitiscardiovascular diseasecancercytokine or immunoglobulin for use in the veterinary field; medical and veterinary laboratory instrumentsclinical chemistry analyzers for medical and veterinary diagnostic use and immunochemistry analyzers for the analysis of biological samples for medical diagnostic use; medical laboratory instruments for performing polymerase chain reaction (PCR) analysis for medical and veterinary diagnostic use; medical devices for use in performing polymerase chain reaction (PCR) for medical and veterinary diagnostic use; apparatus for use in medical analysispolymerase chain reaction (PCR) instruments for medical and veterinary diagnostic use; medical diagnostic instruments for the analysis of body fluids; apparatus for use in medical diagnostic antigen tests and antibody tests for determining infection with respiratory disease or HIV; (Based on 44(e)) diabetes measuring apparatusmedical and veterinary test kits for diabetes monitoring for home use; glycated hemoglobin measuring apparatus; medical and veterinary diagnostic apparatus for detecting atherosclerosis; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; medical and veterinary diagnostic apparatus for testing for bacteria and viruses; medical and veterinary diagnostic apparatus for testing for viruses in urine; veterinary apparatus and instrumentssurgical apparatus and instruments for veterinary use; veterinary apparatussurgical apparatus and instruments for veterinary use; diagnostic apparatus for the detection of respiratorygastrointestinal diseasetropical diseaseviral hepatitiscardiovascular diseasecancercytokine or immunoglobulin for veterinary use; kidney function test equipmentmedical and veterinary diagnostic apparatus for testing kidney functioning; cancer diagnosis measuring apparatusmedical and veterinary apparatus for detecting cancer; genetic testing apparatus for medical and veterinary purposes; electromagnetic medical diagnostic imaging apparatus; genetic testing apparatus for medical purposes; medical ultrasonic diagnostic equipmentmedical ultrasound apparatus; pregnancy testing devicesinstruments and apparatusmulti-drug testing cups for pregnancy testing purposes; immunoassay apparatus for diagnosis being medical instruments to measure fluorescent immunoassayserologic testenzyme-linked immune-specific assay(ELISA)molecular point-of-care (POC) systemautomatic blood chemistry analyzer; blood analysis apparatus for diagnosis being medical instruments to measure fluorescent immunoassayserologic testenzyme-linked immune-specific assay(ELISA)molecular point-of-care (POC) systemautomatic blood chemistry analyzer; ultrasound displaying diagnostic apparatus; devices for measuring blood sugar
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
13/11/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
13/11/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/10/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/10/2024
IUAF
USE AMENDMENT FILED
02/08/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/08/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
26/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/01/2024
PUBO
PUBLISHED FOR OPPOSITION
30/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/12/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
26/12/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26/12/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
26/12/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
26/12/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
14/12/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
18/07/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
05/07/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
30/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/06/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
28/06/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/06/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
28/06/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
28/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/06/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
22/05/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
22/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/02/2023
GNRT
NON-FINAL ACTION E-MAILED
27/02/2023
CNRT
NON-FINAL ACTION WRITTEN
27/02/2023
DOCK
ASSIGNED TO EXAMINER
22/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/06/2022
NWAP
NEW APPLICATION ENTERED
08/06/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIONOTE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.